A thiamin deficiency will cause fatigue, fitful sleep, irritability, and abdominal discomfort
A pilot ketogenic diet trial in PD suggested possible motor improvement, which might be partially due to changes in gut bacteria and their metabolites (ketone bodies can influence gut microbial composition) [174]
Scope: Comprehensive review of ANGPTL3 inhibition as a therapeutic strategy to reduce triglyceride-rich lipoproteins and residual cardiovascular risk Therapeutic approaches discussed: Monoclonal antibodies (e.g., evinacumab) RNA-based therapies (ASOs and siRNA: vupanorsen, zodasiran, solbinsiran) Emerging gene-editing strategies (CRISPR/base editing) Key message: Targeting ANGPTL3 provides robust reductions in triglycerides, apoB-containing lipoproteins, and non-HDL cholesterol, independently of the LDL receptor Clinical relevance: Positions ANGPTL3 inhibition as a next-generation approach for managing mixed dyslipidemia and lipid-related residual risk beyond LDL-C Laura Schreier Natalia Nardelli European Atherosclerosis Society To view or add a comment, sign in Tipping the Scale in MASH: The TZD vs
It remains unclear if there are significant body composition advantages of "peptide therapy" with growth hormone secretagogues
Aphang-Lam M
